Annual EBIT
-$34.00 M
+$54.19 M+61.45%
31 December 2023
Summary:
Finch Therapeutics annual earnings before interest & taxes is currently -$34.00 million, with the most recent change of +$54.19 million (+61.45%) on 31 December 2023. During the last 3 years, it has risen by +$5.43 million (+13.78%). FNCH annual EBIT is now -60.83% below its all-time high of -$20.66 million.FNCH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$6.11 M
-$945.00 K-18.30%
30 June 2024
Summary:
Finch Therapeutics quarterly earnings before interest & taxes is currently -$6.11 million, with the most recent change of -$945.00 thousand (-18.30%) on 30 June 2024. Over the past year, it has dropped by -$2.37 million (-63.56%). FNCH quarterly EBIT is now -63.56% below its all-time high of -$3.73 million, reached on 30 September 2023.FNCH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$19.69 M
+$2.97 M+13.11%
30 June 2024
Summary:
Finch Therapeutics TTM earnings before interest & taxes is currently -$19.69 million, with the most recent change of +$2.97 million (+13.11%) on 30 June 2024. Over the past year, it has increased by +$30.21 million (+60.55%). FNCH TTM EBIT is now -150.40% below its all-time high of -$7.86 million, reached on 31 March 2020.FNCH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.5% | -63.6% | +60.5% |
| 3 y3 years | +13.8% | +38.5% | +63.6% |
| 5 y5 years | - | - | - |
FNCH EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +61.5% | -63.6% | +75.2% | at high | +77.7% |
| 5 y | 5 years | -60.8% | +61.5% | -63.6% | +75.2% | -150.4% | +77.7% |
| alltime | all time | -60.8% | +61.5% | -63.6% | +75.2% | -150.4% | +77.7% |
Finch Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$6.11 M(+18.3%) | -$19.69 M(-13.1%) |
| Mar 2024 | - | -$5.16 M(+10.3%) | -$22.66 M(-33.4%) |
| Dec 2023 | -$34.00 M(-61.4%) | -$4.68 M(+25.3%) | -$34.00 M(-31.9%) |
| Sept 2023 | - | -$3.73 M(-58.9%) | -$49.90 M(-26.0%) |
| June 2023 | - | -$9.08 M(-45.0%) | -$67.47 M(-15.8%) |
| Mar 2023 | - | -$16.51 M(-19.8%) | -$80.12 M(-9.2%) |
| Dec 2022 | -$88.19 M | -$20.58 M(-3.4%) | -$88.19 M(+1.8%) |
| Sept 2022 | - | -$21.30 M(-1.9%) | -$86.67 M(+15.1%) |
| June 2022 | - | -$21.73 M(-11.6%) | -$75.30 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$24.58 M(+28.9%) | -$70.59 M(+17.7%) |
| Dec 2021 | -$59.98 M(+52.1%) | -$19.06 M(+91.9%) | -$59.98 M(+11.0%) |
| Sept 2021 | - | -$9.93 M(-41.6%) | -$54.05 M(-0.3%) |
| June 2021 | - | -$17.02 M(+21.8%) | -$54.20 M(+19.0%) |
| Mar 2021 | - | -$13.97 M(+6.4%) | -$45.55 M(+15.5%) |
| Dec 2020 | -$39.44 M(+86.5%) | -$13.13 M(+30.2%) | -$39.44 M(+49.9%) |
| Sept 2020 | - | -$10.08 M(+20.6%) | -$26.31 M(+62.2%) |
| June 2020 | - | -$8.36 M(+6.3%) | -$16.22 M(+106.3%) |
| Mar 2020 | - | -$7.86 M | -$7.86 M |
| Dec 2019 | -$21.14 M | - | - |
FAQ
- What is Finch Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Finch Therapeutics?
- What is Finch Therapeutics annual EBIT year-on-year change?
- What is Finch Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Finch Therapeutics?
- What is Finch Therapeutics quarterly EBIT year-on-year change?
- What is Finch Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Finch Therapeutics?
- What is Finch Therapeutics TTM EBIT year-on-year change?
What is Finch Therapeutics annual earnings before interest & taxes?
The current annual EBIT of FNCH is -$34.00 M
What is the all time high annual EBIT for Finch Therapeutics?
Finch Therapeutics all-time high annual earnings before interest & taxes is -$20.66 M
What is Finch Therapeutics annual EBIT year-on-year change?
Over the past year, FNCH annual earnings before interest & taxes has changed by +$54.19 M (+61.45%)
What is Finch Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of FNCH is -$6.11 M
What is the all time high quarterly EBIT for Finch Therapeutics?
Finch Therapeutics all-time high quarterly earnings before interest & taxes is -$3.73 M
What is Finch Therapeutics quarterly EBIT year-on-year change?
Over the past year, FNCH quarterly earnings before interest & taxes has changed by -$2.37 M (-63.56%)
What is Finch Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of FNCH is -$19.69 M
What is the all time high TTM EBIT for Finch Therapeutics?
Finch Therapeutics all-time high TTM earnings before interest & taxes is -$7.86 M
What is Finch Therapeutics TTM EBIT year-on-year change?
Over the past year, FNCH TTM earnings before interest & taxes has changed by +$30.21 M (+60.55%)